ATE367821T1 - Folsäure produzierende bifidobacterium bakterienstämme, ihre formulierungen und verwendung - Google Patents

Folsäure produzierende bifidobacterium bakterienstämme, ihre formulierungen und verwendung

Info

Publication number
ATE367821T1
ATE367821T1 AT04770745T AT04770745T ATE367821T1 AT E367821 T1 ATE367821 T1 AT E367821T1 AT 04770745 T AT04770745 T AT 04770745T AT 04770745 T AT04770745 T AT 04770745T AT E367821 T1 ATE367821 T1 AT E367821T1
Authority
AT
Austria
Prior art keywords
genus bifidobacterium
folic acid
species
formulations
acid producing
Prior art date
Application number
AT04770745T
Other languages
English (en)
Inventor
Giovanni Mogna
Gian Paolo Strozzi
Original Assignee
Anidral Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anidral Srl filed Critical Anidral Srl
Priority claimed from EP04770745A external-priority patent/EP1673100B1/de
Application granted granted Critical
Publication of ATE367821T1 publication Critical patent/ATE367821T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT04770745T 2004-08-05 2004-08-05 Folsäure produzierende bifidobacterium bakterienstämme, ihre formulierungen und verwendung ATE367821T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP04770745A EP1673100B1 (de) 2004-08-05 2004-08-05 Folsäure produzierende bifidobacterium bakterienstämme, ihre formulierungen und verwendung

Publications (1)

Publication Number Publication Date
ATE367821T1 true ATE367821T1 (de) 2007-08-15

Family

ID=37989420

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04770745T ATE367821T1 (de) 2004-08-05 2004-08-05 Folsäure produzierende bifidobacterium bakterienstämme, ihre formulierungen und verwendung

Country Status (2)

Country Link
EP (1) EP1800688A1 (de)
AT (1) ATE367821T1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPQ899700A0 (en) 2000-07-25 2000-08-17 Borody, Thomas Julius Probiotic recolonisation therapy
NZ607043A (en) 2010-08-04 2015-05-29 Borody Thomas J Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them
CA2829385C (en) 2011-03-09 2021-07-13 Michael J. Sadowsky Compositions and methods for transplantation of colon microbiota
WO2013176774A1 (en) 2012-05-25 2013-11-28 Arizona Board Of Regents Microbiome markers and therapies for autism spectrum disorders
BR112017024264B1 (pt) 2015-05-14 2022-07-12 Crestovo Holdings Llc Composições para transplante de flora fecal e métodos de preparação e utilização das mesmas, e dispositivos para sua administração
PT3297644T (pt) 2015-05-22 2022-03-30 Univ Arizona State Métodos para tratar distúrbios do espetro do autismo e sintomas associados
US20170360848A1 (en) 2016-06-15 2017-12-21 Arizona Board Of Regents On Behalf Of Arizona State University Methods for treating autism spectrum disorder and associated symptoms
US10849936B2 (en) 2016-07-01 2020-12-01 Regents Of The University Of Minnesota Compositions and methods for C. difficile treatment
US20180036352A1 (en) 2016-08-03 2018-02-08 Crestovo Holdings Llc Methods for treating ulcerative colitis
US10092601B2 (en) 2016-10-11 2018-10-09 Crestovo Holdings Llc Compositions and methods for treating multiple sclerosis and related disorders
WO2018071537A1 (en) 2016-10-11 2018-04-19 Crestovo Holdings Llc Compositions and methods for treating multiple sclerosis and related disorders
WO2018071536A1 (en) 2016-10-11 2018-04-19 Crestovo Holdings Llc Compositions and methods for treating primary sclerosing cholangitis and related disorders
US11040073B2 (en) 2017-04-05 2021-06-22 Finch Therapeutics Holdings Llc Compositions and methods for treating diverticulitis and related disorders
EP3606541A1 (de) 2017-04-05 2020-02-12 Crestovo Holdings LLC Zusammensetzungen und verfahren zur behandlung der parkinson-krankheit (pd) und verwandten erkrankungen
CA3064773A1 (en) 2017-05-26 2018-11-29 Crestovo Holdings Llc Lyophilized compositions comprising fecal microbe-based therapeutic agents and methods for making and using same
CN111328284A (zh) 2017-08-07 2020-06-23 芬奇治疗公司 用于维持和恢复健康的肠道屏障的组合物和方法
US11166990B2 (en) 2018-07-13 2021-11-09 Finch Therapeutics Holdings Llc Methods and compositions for treating ulcerative colitis
AU2019351017A1 (en) 2018-09-27 2021-04-29 Finch Therapeutics Holdings Llc. Compositions and methods for treating epilepsy and related disorders
CN110250270B (zh) * 2019-07-08 2022-03-04 北京工商大学 一种利用植物乳杆菌提高发酵乳叶酸含量的方法
AU2020316330A1 (en) 2019-07-19 2022-01-06 Finch Therapeutics Holdings Llc. Methods and products for treatment of gastrointestinal disorders
CN113481244A (zh) * 2021-08-05 2021-10-08 中科华启(北京)生物技术研究院有限公司 一种复合菌种二裂酵母发酵产物及其在制备化妆品中的应用
CN115154489B (zh) * 2022-06-06 2023-07-21 西北农林科技大学 一种治疗羊干酪性淋巴结炎的多菌群复合制剂及培养物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6368591B2 (en) * 1998-05-15 2002-04-09 Shanghai Sine Pharmaceutical Corporation Ltd. Beneficial microbe composition, new protective materials for the microbes, method to prepare the same and uses thereof
US6468525B1 (en) * 1999-08-10 2002-10-22 Renew Life, Inc. Probiotic formulation
FI20002445A0 (fi) * 2000-11-08 2000-11-08 Raisio Yhtymae Oyj Menetelmä bakteerien seulomiseksi

Also Published As

Publication number Publication date
EP1800688A1 (de) 2007-06-27

Similar Documents

Publication Publication Date Title
ITMI20051509A1 (it) Ceppi di bifidobacterium produttori di acido folico loro formulazioni e uso
ATE367821T1 (de) Folsäure produzierende bifidobacterium bakterienstämme, ihre formulierungen und verwendung
UA111715C2 (uk) Композиція, що містить пробіотичні бактерії для застосування у лікуванні імунних розладів
ATE421256T1 (de) Probiotische zusammensetzung
UA93911C2 (ru) Применение бактериального штамма lactobacillus reuteri dsm 17938 для снижения колик у грудных детей
IL143632A0 (en) Pharmaceutical compositions containing lactobacillus
CA2373255A1 (en) Dietary or pharmaceutical composition for use for the prevention or treatment of hyperoxaluria
SE0402406D0 (sv) Probiotic lactobacillus strains for improved vaginal health
MX2022003373A (es) Composiciones a base de cepas bacterianas y su uso como antiinflamatorios.
MX2022003375A (es) Composiciones a base de cepas bacterianas y extractos de bayas y su uso como antinflamatorios.
WO2009142472A3 (es) Bifidobacteria productora de ácido fólico, composición alimenticia y uso de la bifidobacteria
AR035683A1 (es) Producto de consumo que contiene probioticos
GB0124580D0 (en) New composition
DE602004006133D1 (de) Neue galactooligosaccharidzusammensetzung und herstellung davon
RU2010147343A (ru) ИЗОЛИРОВАННЫЙ ШТАММ МИКРООРГАНИЗМА Lactobacillus plantarum Inducia DSM 21379 В КАЧЕСТВЕ ПРОБИОТИКА, УСИЛИВАЮЩЕГО ВРОЖДЕННЫЙ ИММУНИТЕТ ОРГАНИЗМА, ПРОДУКТ И КОМПОЗИЦИЯ, СОДЕРЖАЩИЕ УПОМОМЯНУТЫЙ МИКРООРГАНИЗМ, И ПРИМЕНЕНИЕ УПОМЯНУТОГО МИКРООРГАНИЗМА ДЛЯ ИЗГОТОВЛЕНИЯ ЛЕКАРСТВЕННОГО СРЕДСТВА, КОТОРОЕ УСИЛИВАЕТ КЛЕТОЧНЫЙ ИММУНИТЕТ
WO2003045405A3 (fr) Bacteries lactiques et leur usage dans le traitement et la prevention du cancer
JP2018007645A5 (de)
UA94056C2 (uk) Застосування специфічних молочнокислих бактерій для одержання імуномодулюючих композицій
TW200700074A (en) Inducer of t cell apoptosis
WO2023281415A3 (en) Bacteria strains for topical skin care
CN116121155B (zh) 一株鼠李糖乳酪杆菌LRa09及其应用与产品
Puniya et al. Probiotic and functional attributes of Lactobacillus spp isolated from human faeces
EE200300220A (et) Bifidobacterium'i perekonna probiootiliste tüvedeskriinimise meetod
DE60218063D1 (de) Milchsäurebakterien der gattung lactococcus lactis und deren verwendung zur konservierung von nahrungsmitteln
Sreeja et al. Oxalate degradation potential of lactic acid bacteria isolated from traditional fermented milk products, human vagina and human faecal matter